about
Anticipatory 50 kHz ultrasonic vocalizations are associated with escalated alcohol intake in dependent rats.Dopamine D1 and μ-opioid receptor antagonism blocks anticipatory 50 kHz ultrasonic vocalizations induced by palatable food cues in Wistar rats.Robust escalation of nicotine intake with extended access to nicotine self-administration and intermittent periods of abstinence.VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation.Virus-mediated shRNA knockdown of prodynorphin in the rat nucleus accumbens attenuates depression-like behavior and cocaine locomotor sensitization.Exposure to chronic intermittent nicotine vapor induces nicotine dependenceGene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats.Low brain allopregnanolone levels mediate flattened circadian activity associated with memory impairments in aged ratsIndividual differences in prefrontal cortex function and the transition from drug use to drug dependenceExtended access nicotine self-administration with periodic deprivation increases immature neurons in the hippocampusκ Opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake.Chronic nicotine activates stress/reward-related brain regions and facilitates the transition to compulsive alcohol drinking.Increased CRF signalling in a ventral tegmental area-interpeduncular nucleus-medial habenula circuit induces anxiety during nicotine withdrawalIndividual differences in cognitive aging: implication of pregnenolone sulfate.Nicotine vapor inhalation escalates nicotine self-administration.Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals.CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats.Effects of the specific α4β2 nAChR antagonist, 2-fluoro-3-(4-nitrophenyl) deschloroepibatidine, on nicotine reward-related behaviors in rats and miceEffects of the combination of metyrapone and oxazepam on intravenous nicotine self-administration in rats.Neurosteroids and cholinergic systems: implications for sleep and cognitive processes and potential role of age-related changes.A Transgenic Rat for Investigating the Anatomy and Function of Corticotrophin Releasing Factor CircuitsControl of craving by the prefrontal cortex.Animal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking.A role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditionsRecruitment of a Neuronal Ensemble in the Central Nucleus of the Amygdala Is Required for Alcohol Dependence.Addiction as a stress surfeit disorder.Long-term antagonism of κ opioid receptors prevents escalation of and increased motivation for heroin intake.Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments.Neuropeptide YY(2)R blockade in the central amygdala reduces anxiety-like behavior but not alcohol drinking in alcohol-dependent rats.Alcohol Dependence Disrupts Amygdalar L-Type Voltage-Gated Calcium Channel Mechanisms.Cortical and amygdalar neuronal ensembles in alcohol seeking, drinking and withdrawal.Deletion of α5 nicotine receptor subunits abolishes nicotinic aversive motivational effects in a manner that phenocopies dopamine receptor antagonism.Genetic and Pharmacologic Manipulation of TLR4 Has Minimal Impact on Ethanol Consumption in Rodents.Craving, context and the cortex.Nicotine Vapor Method to Induce Nicotine Dependence in Rodents.Cebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in Rats.Sleep-wake states and cortical synchronization control by pregnenolone sulfate into the pedunculopontine nucleus.CRF1 Receptor-Dependent Increases in Irritability-Like Behavior During Abstinence from Chronic Intermittent Ethanol Vapor Exposure.Intermittent Access to Ethanol Drinking Facilitates the Transition to Excessive Drinking After Chronic Intermittent Ethanol Vapor Exposure.An enzymatic advance in nicotine cessation therapy.
P50
Q30403588-A60F4021-13D3-41E8-92E4-7052FE4C3680Q30417853-163EBF76-6E3F-43AE-ACBD-51178CAF79CEQ30521108-ECA6D0B4-5C1F-4221-A532-BC91EAF5A512Q30601106-1D789401-9B65-4B48-8543-D35476A60E48Q33591477-6723B5DE-60A9-492C-9924-42455CE3425BQ33886736-6A7AEF4F-2881-4FA6-B9C1-14BFEFA20DB7Q33936233-EF720511-FC6B-4917-A8CA-E418397F0151Q34115885-0F5BED31-4DC2-4064-B453-E35A93BDC7D3Q34203887-28C1CF43-B239-433E-A210-4BE6E2BC85BBQ34980256-67A12469-ED88-4233-B918-1F4B693678BBQ35164085-77E2BD3A-6631-4DA9-B816-16AA23737501Q35423832-BD9E3042-A1DD-4605-B830-E0ADA84046BEQ35518471-1911C7F5-A599-4312-93DD-0012C6B25670Q35581326-F64DD1E7-25BF-4B22-A8AF-841686180EA7Q35892682-9A3A134A-B5AC-4A5F-B2DD-35DE594D192BQ36040481-B08AE2B3-F578-411A-92B2-FF71ED332942Q36089365-9FE8F7F9-8E4C-453D-943D-5795BCDFFE80Q36298187-C7AF3BA9-C410-4432-B49E-4C0161F2A8CBQ36298192-3337728F-A900-4FFD-ABA5-BAF92A275ED3Q36370030-DA252DC9-E9C9-40B2-B851-6625C6394238Q36400644-992407EE-769C-45C5-A8C1-D9FF52D9E121Q36692770-89A09402-9C0F-4591-B3EA-9177270E8239Q36900018-40D15CBA-F8D8-4723-ABB7-0371744917CAQ37208086-62B0080D-25CC-4258-AF0A-EDFF2B70B75DQ37236005-DA20493E-C597-432E-8B7C-60A525E098D5Q37315976-7AD5B326-CF91-43D7-9D4F-951FDD1875F2Q37362473-6AD1421D-99A1-4F7A-9D33-960B20AE556CQ37383580-0B253149-A15C-485D-9F7F-6F13F196CDDCQ37412938-FBD8BF60-F2AE-420E-865C-FCB47E26BA8EQ38863864-FA8157E8-8223-4120-A745-B51CD8CD39F8Q39257483-86C6CFF3-6D54-4FBD-A140-A7C5693F8898Q42028429-A6EAC3AF-D40E-433C-BAA1-ECFE540A8066Q42323311-86875104-1D59-485C-BC28-AFFE7E767533Q42905150-10735B94-DD80-41BE-802F-CC020D918F5DQ43447520-6615B1B0-C589-4D3F-A009-8ADB2B047DECQ44474417-E44CCDDE-8638-4A4F-BB27-5401942888C3Q44893119-E6999B6D-F3E7-435B-83DA-79E2AC76A1E8Q46064548-03ACD4AA-086B-457B-8A23-E87027DC842BQ46257344-43611D54-98BA-4511-96D4-03E8C334973DQ47199097-969894B1-EEE4-4679-89F1-F90D33611446
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Olivier George
@ast
Olivier George
@en
Olivier George
@es
Olivier George
@nl
type
label
Olivier George
@ast
Olivier George
@en
Olivier George
@es
Olivier George
@nl
prefLabel
Olivier George
@ast
Olivier George
@en
Olivier George
@es
Olivier George
@nl
P1153
8134439400
P21
P31
P496
0000-0002-3700-5003